Recall: Tirosint
Feb. 2023Pharmacy Updates
IBSA Pharma Inc. has recalled 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution because these lots may be subpotent (they have a lower than normal or acceptable potency). Read the full text of the Tirosint recall.
Recent Announcements
PA DOH Antibiotic Stewardship Resources
Order antibiotic stewardship resources at no costJun. 2026Important Notices
Medical device correction: Omnipod (Insulet – May 2026)
Insulet Corporation Inc. has announced a medical device correction for certain Omnipod Pods. These pods are wearable devices that are used to deliver insulin.Jun. 2026Pharmacy Updates
Clinical documentation required for medical policy prior authorizations
As you know, UPMC Health Plan requires certain clinical documentation/notes in support of a request for prior authorization for the listed procedures below in accordance with its established policies and procedures, in addition to CMS requirements that medical record documentation must support the medical necessity of the services requested.Jun. 2026Important Notices